科兴制药：科益医药8月已询价转让3%股份 9月拟再询价转让5%股份

Core Points - The core announcement is about Sinovac Biotech (688136.SH) planning to transfer 5% of its shares, equivalent to 10.0628 million shares, through a non-public offering to qualified institutional investors [1] Group 1: Share Transfer Details - The controlling shareholder, Shenzhen Keyi Pharmaceutical Holdings Co., Ltd. (referred to as "Keyi Pharmaceutical"), is initiating the share transfer due to its operational development needs [1] - The transfer will be organized by China International Capital Corporation (CICC), with a minimum transfer price set at 70% of the average stock price over the 20 trading days prior to the issuance of the subscription invitation [1] - Previously, Keyi Pharmaceutical completed a transfer of 6.0377 million shares in August, representing 3% of the total share capital, at a price of 36.70 yuan per share [1] Group 2: Institutional Participation - A total of 13 institutional investors, including ICBC Credit Suisse, Caitong Fund, and J.P. Morgan, successfully acquired shares in the previous transfer, which are subject to a six-month lock-up period [1]